相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib
A. Gokyer et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer
Florian Huemer et al.
CLINICAL COLORECTAL CANCER (2019)
Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice
Tanios Bekaii-Saab et al.
CLINICAL COLORECTAL CANCER (2019)
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
Takayuki Shiroyama et al.
SCIENTIFIC REPORTS (2019)
Total energy intake according to the level of skeletal muscle mass in Korean adults aged 30 years and older: an analysis of the Korean National Health and Nutrition Examination Surveys (KNHANES) 2008-2011 (vol 12, pg 222, 2018)
Bo Young Jang et al.
NUTRITION RESEARCH AND PRACTICE (2019)
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study
Toshikazu Moriwaki et al.
ONCOLOGIST (2018)
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer
Kenji Tsuchihashi et al.
CLINICAL COLORECTAL CANCER (2018)
Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis
Liying He et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review
C. Beaudart et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Response to regorafenib at an initial dose of 120 mg as salvage therapy for metastatic colorectal cancer
Hiroshi Osawa
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer
Naomi Hayashi et al.
ONCOLOGY REPORTS (2016)
Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer
Susanne Blauwhoff-Buskermolen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults
Yuhei Hamaguchi et al.
NUTRITION (2016)
The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature
Hanah N. Rier et al.
ONCOLOGIST (2016)
Meeting An Unmet Need in Metastatic Colorectal Carcinoma with Regorafenib
Barbara Melosky
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING (2016)
Management of regorafenib-related toxicities: a review
Saravanan K. Krishnamoorthy et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2015)
Neutrophil-Lymphocyte Ratio is a Simple and Novel Biomarker for Prediction of Survival after Radioembolization for Metastatic Colorectal Cancer
Samer Tohme et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer
Yuji Miyamoto et al.
PLOS ONE (2015)
Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy
Hee-Won Jung et al.
SUPPORTIVE CARE IN CANCER (2015)
Pretreatment Neutrophil/Lymphocyte Ratio as a Prognostic Aid in Colorectal Cancer
Yavuz Ozdemir et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Liang-Kung Chen et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2014)
The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates
Stephanie A. Studenski et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Axel Grothey et al.
LANCET (2013)
Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
J. R. Lieffers et al.
BRITISH JOURNAL OF CANCER (2012)
Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal Cancer
Hiroshi Sato et al.
WORLD JOURNAL OF SURGERY (2012)
Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia
Roger A. Fielding et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2011)
Sarcopenia: European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft et al.
AGE AND AGEING (2010)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. M. Prado et al.
LANCET ONCOLOGY (2008)
分享论文
